tiprankstipranks
Neuren Pharmaceuticals Limited (AU:NEU)
ASX:NEU
Australian Market

Neuren Pharmaceuticals Limited (NEU) Income Statement

Compare
190 Followers

Neuren Pharmaceuticals Limited Income Statement

Last quarter (Q2 2024), Neuren Pharmaceuticals Limited's total revenue was AU$24.33M, an increase of Infinity% from the same quarter last year. In Q2, Neuren Pharmaceuticals Limited's net income was AU$8.02M. See Neuren Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
AU$ 231.93MAU$ 14.55MAU$ 3.20MAU$ 717.00KAU$ 495.00K
Gross Profit
AU$ 205.17MAU$ 14.54MAU$ 3.19MAU$ 711.00KAU$ 491.00K
Operating Expenses
AU$ 32.70MAU$ 16.14MAU$ 11.42MAU$ 9.52MAU$ 11.57M
Depreciation and Amortization
AU$ 17.00KAU$ 10.00KAU$ 8.00KAU$ 6.00KAU$ 4.00K
EBITDA
AU$ 199.26MAU$ -1.59MAU$ -8.22MAU$ -8.80MAU$ -11.07M
Operating Income
AU$ 172.49MAU$ -1.60MAU$ -11.43MAU$ -9.53MAU$ -11.57M
Other Income/Expenses
AU$ 32.65MAU$ 916.00KAU$ 6.76MAU$ -384.00KAU$ 260.00K
Pretax Income
AU$ 205.14MAU$ -680.00KAU$ -10.99MAU$ -9.91MAU$ -11.31M
Net Income
AU$ 157.08MAU$ 184.00KAU$ -7.79MAU$ -9.19MAU$ -10.82M
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ 1.24AU$ 0.00AU$ -0.07AU$ -0.09AU$ -0.11
Diluted EPS
AU$ 1.20AU$ 0.00AU$ -0.07AU$ -0.09AU$ -0.11
Weighted Average Shares Outstanding
127.07M 125.97M 117.77M 107.06M 100.17M
Weighted Average Shares Outstanding (Diluted)
130.77M 128.91M 117.77M 107.06M 100.17M
Currency in AUD

Neuren Pharmaceuticals Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis